COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study
- PMID: 32632034
- DOI: 10.1136/annrheumdis-2020-218341
COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study
Keywords: antirheumatic agents; systemic vasculitis; tumour necrosis factor inhibitors.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study' by Cuceoglu et al.Ann Rheum Dis. 2021 Jun;80(6):e96. doi: 10.1136/annrheumdis-2020-218364. Epub 2020 Jul 6. Ann Rheum Dis. 2021. PMID: 32632030 No abstract available.
Comment on
-
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study.Ann Rheum Dis. 2020 Jul;79(7):986-988. doi: 10.1136/annrheumdis-2020-217903. Epub 2020 May 28. Ann Rheum Dis. 2020. PMID: 32467245 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical